Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Prepaid Assets of $386.0 million for Q1 2026, up 9.35% year-on-year from $353.0 million in Q1 2025, and up 9.35% on a QoQ basis from $353.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Prepaid Assets (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Prepaid Assets for 10 consecutive years, with $386.0 million the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 9.35% year-over-year to $386.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $386.0 million (up 9.35% YoY) and the FY2026 annual result came in at $386.0 million, up 9.35% from the prior year.
- Prepaid Assets rose to $386.0 million in Q1 2026 per RDY's latest filing, from $353.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for RDY reached as high as $386.0 million in Q1 2026 and fell as low as $183.0 million in Q1 2022.
- A 5-year average of $287.4 million and a median of $271.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets declined 7.58% — and 2023, when it surged 33.33%.
- Year by year, Prepaid Assets stood at $183.0 million in 2022, then jumped by 33.33% to $244.0 million in 2023, then grew by 11.07% to $271.0 million in 2024, then jumped by 30.26% to $353.0 million in 2025, then rose by 9.35% to $386.0 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $386.0 million, $353.0 million, and $271.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 386.00 Mn |
| Mar 31, 2025 | 353.00 Mn |
| Mar 31, 2024 | 271.00 Mn |
| Mar 31, 2023 | 244.00 Mn |
| Mar 31, 2022 | 183.00 Mn |
| Mar 31, 2021 | 198.00 Mn |
| Mar 31, 2020 | 183.00 Mn |
| Mar 31, 2019 | 181.00 Mn |
| Mar 31, 2018 | 220.00 Mn |
| Dec 31, 2009 | 104.00 Mn |
| Sep 30, 2009 | 102.00 Mn |
| Jun 30, 2009 | 105.00 Mn |